Dumato, Ashmar G.
HRN: 27-35-69 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/21/2025
CEFTRIAXONE 1G (VIAL)
06/21/2025
06/28/2025
IV
2g
Od
T/c TBI, Mild; Multiple Soft Tissue Injuries Sec To Rci
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Central Nervous System Compliance to guidelines: